Companies: 10,795·Total market cap: $144.5T

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.

VNDANASDAQHealthcare● Active

$5.94

$-0.09(-1.49%)

Market Cap$357205242

P/E Ratio—

52W High$9.94

52W Low$4.14

Avg Volume1.4M

Open$6.11

Beta0.60

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Vanda Pharmaceuticals Inc.（VNDA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · VNDA · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-4.05Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$217.8MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding58.9MShares outstanding history

Next EarningsJul 30, 2026Est.Earnings history

探索 Vanda Pharmaceuticals Inc. 数据

分析师预测$14 · Buy

股息不分红

营收$216.1M+8.72%

盈利EPS $-3.74-1068.75%

财务快照

FY 2025Revenue$216.1M▲ +8.72% YoY

202320242025

FY 2025Net Income-$220.5M▼ 1066.53% YoY

202320242025

FY 2025EPS$-3.74▼ 1068.75% YoY

202320242025

TTM:Revenue: $217.8MNet Income: -$239.5MEPS: $-4.05View income statement →

分析师评级与目标价

Buy19 位分析师

Strong Buy

0

Buy

13

Hold

5

Sell

1

Strong Sell

0

12-Month Price Target

$7.50Low

$5.94Current

$14.25Avg Target上涨空间 139.90%

$21.00High

合计: 19 · 买入占比: 68.4%

根据过去 3 个月内 19 位华尔街分析师，VNDA 共识评级为 Buy，12 个月平均目标价 $14.25 （较现价 $5.94 上涨空间 139.90%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Vanda Pharmaceuticals Inc.

$5.94-1.49%$357.2M #2

Achieve Life Sciences, Inc.

$5.38+4.76%$551.8M #3

Allogene Therapeutics, Inc.

$1.84-2.13%$448.2M #4

Arcturus Therapeutics Holdings Inc.

$7.13-2.67%$202.5M #5

Atea Pharmaceuticals, Inc.

$4.32+2.35%$345.3M #6

Capricor Therapeutics, Inc.

$26.08-2.43%$1.2B

股票表现

1D-1.08%

1W-3.17%

1M-5.02%

3M-24.40%

YTD-32.37%

1Y+29.96%

5Y-68.20%

关于 Vanda Pharmaceuticals Inc.

CEOMihael H. Polymeropoulos

IPO DateApr 12, 2006

Employees368

CountryUS

Websitevandapharma.com

Vanda Pharmaceuticals Inc. a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETL…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Vanda Pharmaceuticals Inc.（VNDA）是 Biotechnology 行业的 Healthcare 类公司，于 Apr 12, 2006 在 NASDAQ 上市。截至最近交易日，VNDA 股价为 $5.94，市值约为 $357.2M。过去12个月累计回报 +29.96%，年初至今回报 -32.37%。

根据 19 位华尔街分析师，Vanda Pharmaceuticals Inc. 股票共识评级为Buy，12个月平均目标价为 $14.25。2025 财年 Vanda Pharmaceuticals Inc. 营收 $216.1M，净利润 -$220.5M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Vanda Pharmaceuticals Inc.（VNDA）股价为 $5.94，在 NASDAQ 上市，52周区间为 $4.14 – $9.94。

VNDA 最新股价VNDA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议